Feng XH, Derynck R: Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol. 2005, 21: 659-693. 10.1146/annurev.cellbio.21.022404.142018
Article
CAS
PubMed
Google Scholar
Liu T, Feng XH: Regulation of TGF-beta signalling by protein phosphatases. The Biochemical journal. 2010, 430 (2): 191-198. 10.1042/BJ20100427
Article
PubMed Central
CAS
PubMed
Google Scholar
Li AG, Lu SL, Han G, Kulesz-Martin M, Wang XJ: Current view of the role of transforming growth factor beta 1 in skin carcinogenesis. J Investig Dermatol Symp Proc. 2005, 10 (2): 110-117. 10.1111/j.1087-0024.2005.200403.x
Article
CAS
PubMed
Google Scholar
Padua D, Massague J: Roles of TGFbeta in metastasis. Cell research. 2009, 19 (1): 89-102. 10.1038/cr.2008.316
Article
CAS
PubMed
Google Scholar
Harradine KA, Akhurst RJ: Mutations of TGFbeta signaling molecules in human disease. Annals of medicine. 2006, 38 (6): 403-414. 10.1080/07853890600919911
Article
CAS
PubMed
Google Scholar
Slattery ML, Herrick JS, Lundgreen A, Wolff RK: Genetic variation in the TGF-beta signaling pathway and colon and rectal cancer risk. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2011, 20 (1): 57-69.
Article
CAS
Google Scholar
Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui LC, Bapat B, Gallinger S, Andrulis IL: MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell. 1996, 86 (4): 543-552. 10.1016/S0092-8674(00)80128-2
Article
CAS
PubMed
Google Scholar
Uchida K, Nagatake M, Osada H, Yatabe Y, Kondo M, Mitsudomi T, Masuda A, Takahashi T: Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers. Cancer Res. 1996, 56 (24): 5583-5585.
CAS
PubMed
Google Scholar
Yakicier MC, Irmak MB, Romano A, Kew M, Ozturk M: Smad2 and Smad4 gene mutations in hepatocellular carcinoma. Oncogene. 1999, 18 (34): 4879-4883. 10.1038/sj.onc.1202866
Article
CAS
PubMed
Google Scholar
Papadimitrakopoulou VA, Oh Y, El-Naggar A, Izzo J, Clayman G, Mao L: Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer. Clinical cancer research: an official journal of the American Association for Cancer Research. 1998, 4 (3): 539-544.
CAS
Google Scholar
Snijders AM, Schmidt BL, Fridlyand J, Dekker N, Pinkel D, Jordan RC, Albertson DG: Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene. 2005, 24 (26): 4232-4242. 10.1038/sj.onc.1208601
Article
CAS
PubMed
Google Scholar
Takebayashi S, Ogawa T, Jung KY, Muallem A, Mineta H, Fisher SG, Grenman R, Carey TE: Identification of new minimally lost regions on 18q in head and neck squamous cell carcinoma. Cancer research. 2000, 60 (13): 3397-3403.
CAS
PubMed
Google Scholar
Qiu W, Schonleben F, Li X, Su GH: Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4. Cancer letters. 2007, 245 (1-2): 163-170. 10.1016/j.canlet.2006.01.003
Article
PubMed Central
CAS
PubMed
Google Scholar
Hoot KE, Lighthall J, Han G, Lu SL, Li A, Ju W, Kulesz-Martin M, Bottinger E, Wang XJ: Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression. The Journal of clinical investigation. 2008, 118 (8): 2722-2732.
PubMed Central
CAS
PubMed
Google Scholar
Guasch G, Schober M, Pasolli HA, Conn EB, Polak L, Fuchs E: Loss of TGFbeta signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia. Cancer Cell. 2007, 12 (4): 313-327. 10.1016/j.ccr.2007.08.020
Article
PubMed Central
CAS
PubMed
Google Scholar
Maliekal TT, Antony ML, Nair A, Paulmurugan R, Karunagaran D: Loss of expression, and mutations of Smad 2 and Smad 4 in human cervical cancer. Oncogene. 2003, 22 (31): 4889-4897. 10.1038/sj.onc.1206806
Article
CAS
PubMed
Google Scholar
Muro-Cacho CA, Rosario-Ortiz K, Livingston S, Munoz-Antonia T: Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2. Clin Cancer Res. 2001, 7 (6): 1618-1626.
CAS
PubMed
Google Scholar
Xie W, Bharathy S, Kim D, Haffty BG, Rimm DL, Reiss M: Frequent alterations of Smad signaling in human head and neck squamous cell carcinomas: a tissue microarray analysis. Oncology research. 2003, 14 (2): 61-73.
CAS
PubMed
Google Scholar
Waldrip WR, Bikoff EK, Hoodless PA, Wrana JL, Robertson EJ: Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo. Cell. 1998, 92 (6): 797-808. 10.1016/S0092-8674(00)81407-5
Article
CAS
PubMed
Google Scholar
Weinstein M, Yang X, Li C, Xu X, Gotay J, Deng CX: Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2. Proceedings of the National Academy of Sciences of the United States of America. 1998, 95 (16): 9378-9383. 10.1073/pnas.95.16.9378
Article
PubMed Central
CAS
PubMed
Google Scholar
Heyer J, Escalante-Alcalde D, Lia M, Boettinger E, Edelmann W, Stewart CL, Kucherlapati R: Postgastrulation Smad2-deficient embryos show defects in embryo turning and anterior morphogenesis. Proceedings of the National Academy of Sciences of the United States of America. 1999, 96 (22): 12595-12600. 10.1073/pnas.96.22.12595
Article
PubMed Central
CAS
PubMed
Google Scholar
Nomura M, Li E: Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature. 1998, 393 (6687): 786-790. 10.1038/31693
Article
CAS
PubMed
Google Scholar
Ju W, Ogawa A, Heyer J, Nierhof D, Yu L, Kucherlapati R, Shafritz DA, Bottinger EP: Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation. Molecular and cellular biology. 2006, 26 (2): 654-667. 10.1128/MCB.26.2.654-667.2006
Article
PubMed Central
CAS
PubMed
Google Scholar
Hamamoto T, Beppu H, Okada H, Kawabata M, Kitamura T, Miyazono K, Kato M: Compound disruption of smad2 accelerates malignant progression of intestinal tumors in apc knockout mice. Cancer research. 2002, 62 (20): 5955-5961.
CAS
PubMed
Google Scholar
Tannehill-Gregg SH, Kusewitt DF, Rosol TJ, Weinstein M: The roles of Smad2 and Smad3 in the development of chemically induced skin tumors in mice. Vet Pathol. 2004, 41 (3): 278-282. 10.1354/vp.41-3-278
Article
CAS
PubMed
Google Scholar
Xu J, Lamouille S, Derynck R: TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 2009, 19 (2): 156-172. 10.1038/cr.2009.5
Article
CAS
PubMed
Google Scholar
Ikushima H, Miyazono K: TGFbeta signalling: a complex web in cancer progression. Nature reviews Cancer. 2010, 10 (6): 415-424. 10.1038/nrc2853
Article
CAS
PubMed
Google Scholar
Lebrin F, Deckers M, Bertolino P, Ten Dijke P: TGF-beta receptor function in the endothelium. Cardiovascular research. 2005, 65 (3): 599-608. 10.1016/j.cardiores.2004.10.036
Article
CAS
PubMed
Google Scholar
Tian M, Neil JR, Schiemann WP: Transforming growth factor-beta and the hallmarks of cancer. Cellular signalling. 2011, 23 (6): 951-962. 10.1016/j.cellsig.2010.10.015
Article
PubMed Central
CAS
PubMed
Google Scholar
Hoot KE, Oka M, Han G, Bottinger E, Zhang Q, Wang XJ: HGF upregulation contributes to angiogenesis in mice with keratinocyte-specific Smad2 deletion. J Clin Invest. 2010, 120 (10): 3606-3616. 10.1172/JCI43304
Article
PubMed Central
CAS
PubMed
Google Scholar
Huber MA, Kraut N, Beug H: Molecular requirements for epithelial-mesenchymal transition during tumor progression. Current opinion in cell biology. 2005, 17 (5): 548-558. 10.1016/j.ceb.2005.08.001
Article
CAS
PubMed
Google Scholar
Massague J, Gomis RR: The logic of TGFbeta signaling. FEBS Lett. 2006, 580 (12): 2811-2820. 10.1016/j.febslet.2006.04.033
Article
CAS
PubMed
Google Scholar
Piek E, Moustakas A, Kurisaki A, Heldin CH, ten Dijke P: TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. Journal of cell science. 1999, 112 (Pt 24): 4557-4568.
CAS
PubMed
Google Scholar
Valcourt U, Kowanetz M, Niimi H, Heldin CH, Moustakas A: TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Molecular biology of the cell. 2005, 16 (4): 1987-2002. 10.1091/mbc.E04-08-0658
Article
PubMed Central
CAS
PubMed
Google Scholar
Benvenuti S, Comoglio PM: The MET receptor tyrosine kinase in invasion and metastasis. Journal of cellular physiology. 2007, 213 (2): 316-325. 10.1002/jcp.21183
Article
CAS
PubMed
Google Scholar
Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L, Gaudino G, Tamagnone L, Coffer A, Comoglio PM: Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. The Journal of cell biology. 1992, 119 (3): 629-641. 10.1083/jcb.119.3.629
Article
CAS
PubMed
Google Scholar
van de Laar IM, Oldenburg RA, Pals G, Roos-Hesselink JW, de Graaf BM, Verhagen JM, Hoedemaekers YM, Willemsen R, Severijnen LA, Venselaar H: Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nature genetics. 2011, 43 (2): 121-126. 10.1038/ng.744
Article
CAS
PubMed
Google Scholar
Regalado ES, Guo DC, Villamizar C, Avidan N, Gilchrist D, McGillivray B, Clarke L, Bernier F, Santos-Cortez RL, Leal SM: Exome Sequencing Identifies SMAD3 Mutations as a Cause of Familial Thoracic Aortic Aneurysm and Dissection With Intracranial and Other Arterial Aneurysms. Circulation research. 2011, 109 (6): 680-686. 10.1161/CIRCRESAHA.111.248161
Article
PubMed Central
CAS
PubMed
Google Scholar
Ku JL, Park SH, Yoon KA, Shin YK, Kim KH, Choi JS, Kang HC, Kim IJ, Han IO, Park JG: Genetic alterations of the TGF-beta signaling pathway in colorectal cancer cell lines: a novel mutation in Smad3 associated with the inactivation of TGF-beta-induced transcriptional activation. Cancer letters. 2007, 247 (2): 283-292. 10.1016/j.canlet.2006.05.008
Article
CAS
PubMed
Google Scholar
Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N: The consensus coding sequences of human breast and colorectal cancers. Science. 2006, 314 (5797): 268-274. 10.1126/science.1133427
Article
PubMed
Google Scholar
Tram E, Ibrahim-Zada I, Briollais L, Knight JA, Andrulis IL, Ozcelik H: Identification of germline alterations of the mad homology 2 domain of SMAD3 and SMAD4 from the Ontario site of the breast cancer family registry (CFR). Breast cancer research: BCR. 2011, 13 (4): R77. 10.1186/bcr2926
Article
PubMed Central
CAS
PubMed
Google Scholar
Riggins GJ, Kinzler KW, Vogelstein B, Thiagalingam S: Frequency of Smad gene mutations in human cancers. Cancer research. 1997, 57 (13): 2578-2580.
CAS
PubMed
Google Scholar
Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, Fakhry C, Xie TX, Zhang J, Wang J: Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 2011, 333 (6046): 1154-1157. 10.1126/science.1206923
Article
PubMed Central
CAS
PubMed
Google Scholar
Mhawech-Fauceglia P, Kesterson J, Wang D, Akers S, Dupont NC, Clark K, Lele S, Liu S: Expression and clinical significance of the transforming growth factor-beta signalling pathway in endometrial cancer. Histopathology. 2011, 59 (1): 63-72. 10.1111/j.1365-2559.2011.03892.x
Article
PubMed
Google Scholar
Han SU, Kim HT, Seong DH, Kim YS, Park YS, Bang YJ, Yang HK, Kim SJ: Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer. Oncogene. 2004, 23 (7): 1333-1341. 10.1038/sj.onc.1207259
Article
CAS
PubMed
Google Scholar
Wolfraim LA, Fernandez TM, Mamura M, Fuller WL, Kumar R, Cole DE, Byfield S, Felici A, Flanders KC, Walz TM: Loss of Smad3 in acute T-cell lymphoblastic leukemia. The New England journal of medicine. 2004, 351 (6): 552-559. 10.1056/NEJMoa031197
Article
CAS
PubMed
Google Scholar
Millet C, Zhang YE: Roles of Smad3 in TGF-beta signaling during carcinogenesis. Critical reviews in eukaryotic gene expression. 2007, 17 (4): 281-293.
Article
PubMed Central
CAS
PubMed
Google Scholar
Bae DS, Blazanin N, Licata M, Lee J, Glick AB: Tumor suppressor and oncogene actions of TGFbeta1 occur early in skin carcinogenesis and are mediated by Smad3. Molecular carcinogenesis. 2009, 48 (5): 441-453. 10.1002/mc.20482
Article
PubMed Central
CAS
PubMed
Google Scholar
Vijayachandra K, Lee J, Glick AB: Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model. Cancer research. 2003, 63 (13): 3447-3452.
CAS
PubMed
Google Scholar
Yang YA, Zhang GM, Feigenbaum L, Zhang YE: Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2. Cancer cell. 2006, 9 (6): 445-457. 10.1016/j.ccr.2006.04.025
Article
PubMed Central
CAS
PubMed
Google Scholar
Zhu Y, Richardson JA, Parada LF, Graff JM: Smad3 mutant mice develop metastatic colorectal cancer. Cell. 1998, 94 (6): 703-714. 10.1016/S0092-8674(00)81730-4
Article
CAS
PubMed
Google Scholar
Datto MB, Frederick JP, Pan L, Borton AJ, Zhuang Y, Wang XF: Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction. Molecular and cellular biology. 1999, 19 (4): 2495-2504.
Article
PubMed Central
CAS
PubMed
Google Scholar
Yang X, Letterio JJ, Lechleider RJ, Chen L, Hayman R, Gu H, Roberts AB, Deng C: Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. The EMBO journal. 1999, 18 (5): 1280-1291. 10.1093/emboj/18.5.1280
Article
PubMed Central
CAS
PubMed
Google Scholar
Maggio-Price L, Treuting P, Zeng W, Tsang M, Bielefeldt-Ohmann H, Iritani BM: Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice. Cancer research. 2006, 66 (2): 828-838. 10.1158/0008-5472.CAN-05-2448
Article
CAS
PubMed
Google Scholar
Li AG, Lu SL, Zhang MX, Deng C, Wang XJ: Smad3 knockout mice exhibit a resistance to skin chemical carcinogenesis. Cancer research. 2004, 64 (21): 7836-7845. 10.1158/0008-5472.CAN-04-1331
Article
CAS
PubMed
Google Scholar
Patamalai B, Burow DL, Gimenez-Conti I, Zenklusen JC, Conti CJ, Klein-Szanto AJ, Fischer SM: Altered expression of transforming growth factor-beta 1 mRNA and protein in mouse skin carcinogenesis. Molecular carcinogenesis. 1994, 9 (4): 220-229. 10.1002/mc.2940090406
Article
CAS
PubMed
Google Scholar
Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH: DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science. 1996, 271 (5247): 350-353. 10.1126/science.271.5247.350
Article
CAS
PubMed
Google Scholar
Zhang Y, Feng X, We R, Derynck R: Receptor-associated Mad homologues synergize as effectors of the TGF-beta response. Nature. 1996, 383 (6596): 168-172. 10.1038/383168a0
Article
CAS
PubMed
Google Scholar
Thiagalingam S, Lengauer C, Leach FS, Schutte M, Hahn SA, Overhauser J, Willson JK, Markowitz S, Hamilton SR, Kern SE: Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nature genetics. 1996, 13 (3): 343-346. 10.1038/ng0796-343
Article
CAS
PubMed
Google Scholar
Howe JR, Roth S, Ringold JC, Summers RW, Jarvinen HJ, Sistonen P, Tomlinson IP, Houlston RS, Bevan S, Mitros FA: Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science. 1998, 280 (5366): 1086-1088. 10.1126/science.280.5366.1086
Article
CAS
PubMed
Google Scholar
Miyaki M, Kuroki T: Role of Smad4 (DPC4) inactivation in human cancer. Biochemical and biophysical research communications. 2003, 306 (4): 799-804. 10.1016/S0006-291X(03)01066-0
Article
CAS
PubMed
Google Scholar
Yang G, Yang X: Smad4-mediated TGF-beta signaling in tumorigenesis. International journal of biological sciences. 2010, 6 (1): 1-8.
Article
PubMed Central
CAS
PubMed
Google Scholar
Bornstein S, White R, Malkoski S, Oka M, Han G, Cleaver T, Reh D, Andersen P, Gross N, Olson S: Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation. The Journal of clinical investigation. 2009, 119 (11): 3408-3419.
PubMed Central
CAS
PubMed
Google Scholar
Kim SK, Fan Y, Papadimitrakopoulou V, Clayman G, Hittelman WN, Hong WK, Lotan R, Mao L: DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. Cancer research. 1996, 56 (11): 2519-2521.
CAS
PubMed
Google Scholar
Fukuchi M, Masuda N, Miyazaki T, Nakajima M, Osawa H, Kato H, Kuwano H: Decreased Smad4 expression in the transforming growth factor-beta signaling pathway during progression of esophageal squamous cell carcinoma. Cancer. 2002, 95 (4): 737-743. 10.1002/cncr.10727
Article
CAS
PubMed
Google Scholar
Natsugoe S, Xiangming C, Matsumoto M, Okumura H, Nakashima S, Sakita H, Ishigami S, Baba M, Takao S, Aikou T: Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus. Clinical cancer research: an official journal of the American Association for Cancer Research. 2002, 8 (6): 1838-1842.
CAS
Google Scholar
Wang X, Sun W, Bai J, Ma L, Yu Y, Geng J, Qi J, Shi Z, Fu S: Growth inhibition induced by transforming growth factor-beta1 in human oral squamous cell carcinoma. Molecular biology reports. 2009, 36 (5): 861-869. 10.1007/s11033-008-9256-x
Article
CAS
PubMed
Google Scholar
Sirard C, de la Pompa JL, Elia A, Itie A, Mirtsos C, Cheung A, Hahn S, Wakeham A, Schwartz L, Kern SE: The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev. 1998, 12 (1): 107-119. 10.1101/gad.12.1.107
Article
PubMed Central
CAS
PubMed
Google Scholar
Yang X, Li C, Xu X, Deng C: The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice. Proc Natl Acad Sci USA. 1998, 95 (7): 3667-3672. 10.1073/pnas.95.7.3667
Article
PubMed Central
CAS
PubMed
Google Scholar
Yang L, Mao C, Teng Y, Li W, Zhang J, Cheng X, Li X, Han X, Xia Z, Deng H: Targeted disruption of Smad4 in mouse epidermis results in failure of hair follicle cycling and formation of skin tumors. Cancer research. 2005, 65 (19): 8671-8678. 10.1158/0008-5472.CAN-05-0800
Article
CAS
PubMed
Google Scholar
Qiao W, Li AG, Owens P, Xu X, Wang XJ, Deng CX: Hair follicle defects and squamous cell carcinoma formation in Smad4 conditional knockout mouse skin. Oncogene. 2006, 25 (2): 207-217.
CAS
PubMed
Google Scholar
Teng Y, Sun AN, Pan XC, Yang G, Yang LL, Wang MR, Yang X: Synergistic function of Smad4 and PTEN in suppressing forestomach squamous cell carcinoma in the mouse. Cancer research. 2006, 66 (14): 6972-6981. 10.1158/0008-5472.CAN-06-0507
Article
CAS
PubMed
Google Scholar
Li W, Qiao W, Chen L, Xu X, Yang X, Li D, Li C, Brodie SG, Meguid MM, Hennighausen L: Squamous cell carcinoma and mammary abscess formation through squamous metaplasia in Smad4/Dpc4 conditional knockout mice. Development. 2003, 130 (24): 6143-6153. 10.1242/dev.00820
Article
CAS
PubMed
Google Scholar
Kutler DI, Auerbach AD, Satagopan J, Giampietro PF, Batish SD, Huvos AG, Goberdhan A, Shah JP, Singh B: High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Archives of otolaryngology--head & neck surgery. 2003, 129 (1): 106-112. 10.1001/archotol.129.1.106
Article
Google Scholar
Owens P, Engelking E, Han G, Haeger SM, Wang XJ: Epidermal Smad4 deletion results in aberrant wound healing. AmJPathol. 2010, 176 (1): 122-133.
CAS
Google Scholar
Bardeesy N, Cheng KH, Berger JH, Chu GC, Pahler J, Olson P, Hezel AF, Horner J, Lauwers GY, Hanahan D: Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes & development. 2006, 20 (22): 3130-3146. 10.1101/gad.1478706
Article
CAS
Google Scholar